当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
201019 LIDOCAINE 23% / TETRACAINE 7%
HUMAN COMPOUNDED DRUG
72934-5402
SKNV
2024-2
LIDOCAINE; TETRACAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
23 g/100 mL; 7 g/100 mL
72934-5402-4
351036 CICLOPIROX 0.77% / SALICYLIC ACID 2%
HUMAN COMPOUNDED DRUG
72934-7425
SKNV
2024-2
CICLOPIROX OLAMINE; SALICYLIC ACID
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.77 g/100 mL; 2 g/100 mL
72934-7425-6
031041 FLUOCINOLONE ACETONIDE 0.01% / MINOXIDIL 5% / TRETINOIN 0.025%
HUMAN COMPOUNDED DRUG
72934-4348
SKNV
2024-2
MINOXIDIL; TRETINOIN; FLUOCINOLONE ACETONIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 g/100 mL; .025 g/100 mL; .01 g/100 mL
72934-4348-8
141060 HYDROCORTISONE 0.5% / HYDROQUINONE 4% / TRETINOIN 0.025%
HUMAN COMPOUNDED DRUG
72934-6386
SKNV
2024-2
HYDROCORTISONE; HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.5 g/100 mL; 4 g/100 mL; .025 g/100 mL
72934-6386-2
091092 CLOBETASOL PROPIONATE 0.05% / NIACINAMIDE 4%
HUMAN COMPOUNDED DRUG
72934-2364
SKNV
2024-2
NIACINAMIDE; CLOBETASOL PROPIONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 g/100 mL; .05 g/100 mL
72934-2364-3
221034 LIDOCAINE 5% / SALICYLIC ACID 40%
HUMAN COMPOUNDED DRUG
72934-1436
SKNV
2024-2
SALICYLIC ACID; LIDOCAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 g/100 mL; 5 g/100 mL
72934-1436-2
221012 IBUPROFEN 2% / SALICYLIC ACID 17%
HUMAN COMPOUNDED DRUG
72934-1435
SKNV
2024-2
IBUPROFEN; SALICYLIC ACID
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 g/100 mL; 17 g/100 mL
72934-1435-2
011019 CLINDAMYCIN 1% / NIACINAMIDE 4%
HUMAN COMPOUNDED DRUG
72934-3303
SKNV
2024-2
NIACINAMIDE; CLINDAMYCIN PHOSPHATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 g/100 mL; 1 g/100 mL
72934-3303-3
011014 CLINDAMYCIN 1% / NIACINAMIDE 4% / TRETINOIN 0.025%
HUMAN COMPOUNDED DRUG
72934-2302
SKNV
2024-2
CLINDAMYCIN PHOSPHATE; TRETINOIN; NIACINAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 g/100 mL; .025 g/100 mL; 4 g/100 mL
72934-2302-2
091040 KETOCONAZOLE 2% / NIACINAMIDE 4%
HUMAN COMPOUNDED DRUG
72934-2363
SKNV
2024-1
KETOCONAZOLE; NIACINAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 g/100 mL; 4 g/100 mL
72934-2363-2
011519 BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.05%
HUMAN COMPOUNDED DRUG
72934-1328
SKNV
2024-1
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE; NIACINAMIDE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2.5 g/100 mL; 1 g/100 mL; 2 g/100 mL; .05 g/100 mL
72934-1328-2
021011 DICLOFENAC SODIUM 3% / NIACINAMIDE 4% Gel
HUMAN COMPOUNDED DRUG
72934-1338
SKNV
2024-1
DICLOFENAC SODIUM; NIACINAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3 g/100 mL; 4 g/100 mL
72934-1338-2
BENZOCAINE/LIDOCAINE HCL/TETRACAINE HCL 20%/6%/4%
HUMAN COMPOUNDED DRUG
73271-1006
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
LIDOCAINE; TETRACAINE; BENZOCAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.06 g; .04 g; .2 g
73271-1006-1
TESTOSTERONE 18 PEL
HUMAN COMPOUNDED DRUG
73271-0180
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
18 mg
73271-0180-1
LIDOCAINE HCL/EPINEPHRINE BITARTRATE/TETRACAINE HCL 4%/0.18%/0.5%
HUMAN COMPOUNDED DRUG
73271-1003
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
TETRACAINE; EPINEPHRINE BITARTRATE; LIDOCAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.005 g; .0018 g; .04 g
73271-1003-1
TESTOSTERONE 12.5 PEL
HUMAN COMPOUNDED DRUG
73271-1125
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
12.5 mg
73271-1125-1
TESTOSTERONE 100 PEL
HUMAN COMPOUNDED DRUG
73271-1100
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg
73271-1100-1
ESTRADIOL 25 PEL
HUMAN COMPOUNDED DRUG
73271-0025
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg
73271-0025-1
ESTRADIOL 15 PEL
HUMAN COMPOUNDED DRUG
73271-0015
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
15 mg
73271-0015-1
ESTRADIOL 20MG
HUMAN COMPOUNDED DRUG
70713-145
Wells Pharmacy, Inc
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg
70713-145-01
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3